Fetal hemoglobin in sickle cell anemia: A glass half full?

Blood

Volumn 123, Issue 4, 2014, Pages 481-485

  Steinberg, Martin H ^a   Chui, David H K ^a   Dover, George J ^b   Sebastiani, Paola ^c   Alsultan, Abdulrahman ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d AL Amodi Autism Research Chair   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN BETA CHAIN; HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA;

ACUTE CHEST SYNDROME; AFRICAN AMERICAN; BLOOD; BONE NECROSIS; ERYTHROCYTE; GENE DELETION; HAPLOTYPE; HETEROZYGOSITY; HUMAN; MEAN CORPUSCULAR HEMOGLOBIN; MORBIDITY; PATHOPHYSIOLOGY; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA;

ADULT; ANEMIA, SICKLE CELL; ERYTHROCYTES; FETAL HEMOGLOBIN; GENE DELETION; HAPLOTYPES; HEMOGLOBIN, SICKLE; HETEROZYGOTE; HUMANS; HYDROXYUREA; MODELS, THEORETICAL; MULTIGENE FAMILY; PHENOTYPE; POLYMERS;

EID: 84893081193     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-09-528067     Document Type: Review

References (26)

1. Eaton WA, Hofrichter J. Hemoglobin S gelation (Pubitemid 18026123)
2. Solovieff N, Milton JN, Hartley S.W., et al. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 59 olfactory receptor gene cluster. Blood. 2010; 115(9): 1815-1822.
3. Sankaran VG, Xu J, Orkin SH. Advances in the understanding of haemoglobin switching. Br J Haematol. 2010; 149(2): 181-194.
4. Wilber A, Nienhuis AW, Persons DA. Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities. Blood. 2011; 117(15): 3945-3953.
5. Steinberg MH, Lu ZH, Barton F.B., Terrin ML, Charache S, Dover GJ; Multicenter Study of Hydroxyurea. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Blood. 1997; 89(3): 1078-1088. (Pubitemid 27121303)
6. Mundee Y, Bigelow NC, Davis B.H., Porter JB. Flow cytometric method for simultaneous assay of foetal haemoglobin containing red cells, reticulocytes and foetal haemoglobin containing reticulocytes. Clin Lab Haematol. 2001; 23(3): 149-154. (Pubitemid 34204406)
7. Dover GJ, Boyer SH. Hemoglobin determinations in single cells: Comparison of different techniques. Prog Clin Biol Res. 1981; 60: 115-133.
8. Boyer SH, Belding TK, Margolet L, Noyes AN. Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. Science. 1975; 188(4186): 361-363.
9. Dover GJ, Boyer SH. Quantitation of hemoglobins within individual red cells: asynchronous biosynthesis of fetal and adult hemoglobin during erythroid maturation in normal subjects. Blood. 1980; 56(6): 1082-1091. (Pubitemid 11205065)
10. Maier-Redelsperger M., Noguchi CT, de Montalembert M, et al. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease. Blood. 1994; 84(9): 3182-3188. (Pubitemid 24328113)
11. Hosoi T. Studies on Hemoglobin F within single erythrocyte by fluorescent antibody technique. Exp Cell Res. 1965; 37: 680-683.
12. Horiuchi K, Osterhout ML, Kamma H, Bekoe N.A., Hirokawa KJ. Estimation of fetal hemoglobin levels in individual red cells via fluorescence image cytometry. Cytometry. 1995; 20(3): 261-267.
13. Ngo DA, Aygun B, Akinsheye I., et al. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin. Br J Haematol. 2012; 156(2): 259-264.
14. Brittenham GM, Schechter AN, Noguchi CT. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes. Blood. 1985; 65(1): 183-189. (Pubitemid 15191056)
15. Akinsheye I, Alsultan A, Solovieff N., et al. Fetal hemoglobin in sickle cell anemia. Blood. 2011; 118(1): 19-27.
16. Adekile AD. Limitations of Hb F as a phenotypic modifier in sickle cell disease: study of Kuwaiti Arab patients. Hemoglobin. 2011; 35(5-6): 607-617.
17. Alsultan A, Alabdulaali MK, Griffin P.J., et al. Sickle cell disease in Saudi Arabia: The phenotype in adults with the Arab-Indian haplotype is not benign [published online ahead of print November 13, 2013]. Br J Haematol. doi: 10.1111/bjh.12650.
18. Akinsheye I, Solovieff N, Ngo D., et al. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans. Am J Hematol. 2012; 87(2): 217-219.
19. Steinberg MH, Barton F, Castro O., et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003; 289(13): 1645-1651. (Pubitemid 37430269)
20. Steinberg MH, McCarthy WF, Castro O, et al. The safety and effectiveness of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am J Hematol. 2010; 85: 403-408.
21. Gupta AK, Nadarajah S. Handbook of Beta Distribution and Its Applications. New York: Marcel Dekker; 2004.
22. Platt OS, Brambilla DJ, Rosse W.F., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994; 330(23): 1639-1644.
23. Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol. 2012; 87(8): 795-803.
24. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007; 21(1): 37-47. (Pubitemid 46110926)
25. Powars DR, Weiss JN, Chan L.S., Schroeder WA. Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood. 1984; 63(4): 921-926. (Pubitemid 14141316)
26. Xu J, Peng C, Sankaran V.G., et al. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science. 2011; 334(6058): 993-996.